Michael Kim-Orden, MD
Adult Reconstructive Orthopaedic Surgery · Fountain Valley, CANPI 1326457839
Payments from drug & device makers
What this record shows
This record is dominated by education: $108,000 of the $119,352 with a category attached, or 90.5%. Smith+Nephew accounts for 91.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $49,430 and has fallen 97.8% since, to $1,082 in 2025.
Across 84 payments — averaging $1420.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$109K
- Biogennix, LLC$7K
- Stryker$3K
- Medical Device Business Services, Inc.$163
- Icotec Medical Inc.$155
- Fisher & Paykel Healthcare Inc$24
- plus $38 from 2 others
What the payments were for
- Consulting fees$7,0006%
- Travel & lodging$1,0801%
- Food & beverage$3,2723%
- Education$108,00090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 15 | $109,314 |
| Biogennix, LLC | 1 | $7,000 |
| Stryker | 60 | $2,658 |
| Medical Device Business Services, Inc. | 4 | $163 |
| Icotec Medical Inc. | 1 | $155 |
| Fisher & Paykel Healthcare Inc | 1 | $24 |
| Orthalign Inc | 1 | $20 |
| Paragon 28, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Agilon Surgical Matrix$7,000
- REDAPT Revision Hip System$781
- MAKO$538
- Journey II XR$424
- POLARSTEM$424
- Legion Revision$357
- GAMMA$334
- Taylor Spatial Frame$185
- EVOS$185
- Vader Pedicle System$155
- ASNIS$144
How this compares
$119,352 in reported general payments places this provider in the 80th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 27 | $106 |
| Meloxicam | 31 | $86 |
| Cephalexin | 15 | $79 |
| Tramadol Hcl | 16 | $45 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Fountain Valley
- Nikhil ChokshiFountain Valley$40K
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- William LongLos Angeles$2.8M
- John DearbornMenlo Park$2.5M
- William Bugbeela Jolla$2.1M
- James HuddlestonStanford$1.5M
- Alexander SahFremont$1.2M
- John DianaNapa$981K
- Thomas DonaldsonColton$893K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.